Filing Details

Accession Number:
0001415889-17-000882
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-01 16:56:06
Reporting Period:
2017-05-31
Filing Date:
2017-06-01
Accepted Time:
2017-06-01 16:56:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411685 Vistagen Therapeutics Inc. VTGN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
901014 B Jerry Gin C/O Vistagen Therapeutics, Inc.
343 Allerton Avenue
South San Francisco CA 94080
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-31 50,000 $0.00 50,000 No 4 P Indirect By Jermax, LLC
Common Stock Acquisiton 2017-05-31 50,000 $0.00 100,000 No 4 P Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Jermax, LLC
No 4 P Indirect By Spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant Acquisiton 2017-05-31 25,000 $0.00 25,000 $4.00
Common Stock Warrant Acquisiton 2017-05-31 25,000 $0.00 25,000 $4.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,000 2017-12-01 2021-04-30 No 4 P Indirect
50,000 2017-12-01 2021-04-30 No 4 P Indirect
Footnotes
  1. Reporting Person purchased fifty thousand (50,000) Units, at a per-Unit cost of two dollars ($2.00), in the Issuer's private placement, each Unit consisting of one (1) share of unregistsered Common Stock and a warrant to purchase one-half (0.5) share of unregistered Common Stock at an exercise price of $4.00 per share.
  2. Jermax, LLC is wholly owned and controlled by the Reporting Person.
  3. Reporting Person's spouse purchased fifty thousand (50,000) Units, at a per-Unit cost of two dollars ($2.00), in the Issuer's private placement, each Unit consisting of one (1) share of unregistsered Common Stock and a warrant to purchase one-half (0.5) share of unregistered Common Stock at an exercise price of $4.00 per share.
  4. Shares are held by Pegmax, LLC, which is wholly owned and controlled by the Reporting Person's spouse, Margaret P. Gin.